Aurora Cannabis laid the foundation to raise up to $750 million (1 billion Canadian dollars) to fuel possible future acquisitions, other capital expenditures and debt repayments.

The Edmonton, Alberta-primarily based business filed a base shelf prospectus with Canadian securities agencies and a corresponding shelf registration statement with the U.S. Securities and Exchange Commission.

The filing would clear the way for Aurora to problem debt securities, warrants, subscription receipts and units or prevalent shares for a 25-month period, the business mentioned in a news release.

Study the prospectus right here.

As of Dec. 31, 2018, Aurora had money and money equivalents of CA$88 million, down sharply from CA$147 million as of Sept. 30, 2018.

The CA$1 billion would add to the CA$200 million the business raised earlier this year.

Demonstrating the capital specifications of organizations such as Aurora, the firm’s giant cannabis greenhouse in Alberta came in more than spending budget at CA$150 million. The business lately mentioned the facility is completely licensed.

“With our current listing on the (New York Stock Exchange), our prosperous financing in January 2019 led by U.S. institutional investors, and as we perform with Nelson Peltz to discover possible partnership possibilities, this filing is a all-natural evolution for our business as we swiftly mature into a worldwide and lucrative organization,” Executive Chairman Michael Singer mentioned in the release.

Aurora trades as ACB on the New York Stock Exchange and Toronto Stock Exchange.